Are these beaten down ASX shares in the bargain bin?

Earlier today I wrote about a few shares that had just reached 52-week highs or better today.

Unfortunately, not all shares have been so fortunate. In fact, some have made the unwanted milestone of a a 52-week low today.

Three that did this are listed below. Are they in the bargain bin?

The Experience Co Ltd (ASX: EXP) share price fell to a 52-week low of 45.5 cents today. This adventure tourism company has come under significant pressure this year after a once-in-a-generation weather event impacted many of its businesses. While this is undoubtedly a disappointment, I expect the company to bounce back strongly next year should weather conditions permit. This could make it well worth considering a small investment whilst its shares are down so low.

The Medical Developments International Ltd (ASX: MVP) share price dropped to a 52-week low of $5.04 today. Two disappointing announcements have been behind the healthcare company’s 43% year-to-date decline. The first was a trading update in May that revealed that sales would be flat at best in FY 2018. The second was an announcement released last week advising that the U.S. Food and Drug Administration has suspended the clinical program for its Penthrox pain management in the USA. Unfortunately, it could be upwards of two months before the company receives a letter outlining the regulatory body’s outstanding issues and concerns. I suspect its shares will remain under pressure until the receipt of this letter.

The Pendal Group Ltd (ASX: PDL) share price hit a 52-week low of $8.90 today. The fund manager, previously known as BT Investment Management, has fallen out of favour with investors after it released a weak funds under management update. In the last quarter its JO Hambro business in the UK saw net fund outflows of $1.1 billion. In addition to this, Westpac Banking Corp (ASX: WBC) is believed to be wanting to offload its remaining stake in the company. While it looks cheap, I would hold off an investment until its funds under management are heading in the right direction.

Instead, I would be buying one of these top buy-rated shares.

The Disruptors: 3 Revolutionary Aussie Companies to Back for 2018

We’re living in one of the most exciting times in investing history. Innovation and a booming culture of entrepreneurship are constantly creating new companies with the potential to make forward-thinking investors very rich. Now more than ever, one small, smart investment could make a huge difference to your wealth.

That’s why at The Motley Fool we’ve been scrutinizing the ASX to uncover the kinds of companies that we believe could turn into the next Atlassian.

We’ve found three exciting companies that we believe re poised to perform in the new year. Click here to uncover these ideas!

Motley Fool contributor James Mickleboro owns shares of Westpac Banking. The Motley Fool Australia owns shares of EXPERNCECO FPO. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The 5 mining stocks we’re recommending in 2019…

For decades, Australian mining companies have minted money for individual investors like you and me. But if you believe the pundits and talking heads on TV, those days are long gone. Finito! Behind us forever…

We say nothing could be further from the truth. To earn the really massive returns, you’ve got to fish where others aren’t fishing—and the mining sector could be primed for a resurgence. That’s why top Motley Fool analysts just revealed their exciting new research on 5 ASX miners they believe could help you profit in 2019 and beyond…


The best way we see to play the global zinc shortage… Our #1 favourite large-cap miner (hint: it’s not BHP)… one early-stage gold miner we think could hit the motherlode… Plus two more surprising companies you probably haven’t heard of yet!

For free access to our brand-new research, simply click here or the link below. But be warned, this research is available free for a limited time only, and we reserve the right to withdraw it at any time.

Click here for your FREE report!